Trial Profile
Brodalumab in a randomised, open, phase IV study evaluating clinical efficacy in psoriasis patients switching from TNF-alpha inhibitor treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2020
Price :
$35
*
At a glance
- Drugs Brodalumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 04 Oct 2020 Status changed from recruiting to completed.
- 12 Oct 2018 New trial record